News

Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...
The START Center for Cancer Research ("START"), the world's largest early-phase community-based oncology site network, today ...
The anti-mRNA sentiment — coupled with the sweeping shake-up of science funding across the United States — has sparked fears ...
Whether you’re working in a startup, academic lab, or biopharma R&D team, this eBook offers a window into what’s working now and what’s possible next.
Deb Hart; Head, Investor Relations; Maravai LifeSciences Holdings Inc. William Martin; Chief Executive Officer; Maravai LifeSciences Holdings Inc. Kevin Herde; Chief ...
Most vaccines—and boosters—are injected directly into muscle tissue, usually in the upper arm, to kickstart the body's immune ...
Good afternoon, everyone, and welcome to the Maravai LifeSciences Q1 2025 Results Earnings Call. [Operator Instructions] Also, today's call is being recorded. [Operator Instructions] At this time, ...
Nonhuman primate (NHP) study in hemophilia A demonstrated therapeutically relevant factor VIII (FVIII) activity with durable response through approximately 19 months with an encouraging safety profile ...
Therefore, mRNA vaccine design, formulation, and delivery will need to be further improved to compete in this area; and self-amplifying RNAs (saRNA) may become a preferred platform, due to ...
EMERYVILLE, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its ...
Cash, cash equivalents and short-term investments were $83.1 million as of March 31, 2025, compared to $125.7 million as of December 31, 2024. Adverum expects its cash, cash equivalents and short-term ...